BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38509729)

  • 1. HBI-8000 improves heart failure with preserved ejection fraction via the TGF-β1/MAPK signalling pathway.
    Tian J; Li W; Zeng L; Li Y; Du J; Li Y; Li B; Su G
    J Cell Mol Med; 2024 Apr; 28(7):e18238. PubMed ID: 38509729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects and mechanism of Compound Qidan Formula on rats with HFpEF induced by hypertension and diabetes mellitus based on Ang Ⅱ/TGF-β1/Smads signaling pathway.
    Yuan P; Liu J; Xiong S; Yang L; Guan J; Dong G; Shi D
    J Ethnopharmacol; 2023 Sep; 313():116558. PubMed ID: 37116729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ling-Gui-Qi-Hua formula alleviates left ventricular myocardial fibrosis in rats with heart failure with preserved ejection fraction by blocking the transforming growth factor-β1 /Smads signaling pathway.
    Shi Y; Liu C; Xiong S; Yang L; Yang C; Qiao W; Liu Y; Liu S; Liu J; Dong G
    J Ethnopharmacol; 2023 Dec; 317():116849. PubMed ID: 37385575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling.
    Marunouchi T; Matsumura K; Fuji E; Iwamoto A; Tanonaka K
    Pharmacology; 2024; 109(1):43-51. PubMed ID: 38016432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction.
    Shi YJ; Yang CG; Qiao WB; Liu YC; Liu SY; Dong GJ
    Eur J Pharmacol; 2023 Dec; 961():176170. PubMed ID: 37939991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice.
    Reddy SS; Agarwal H; Barthwal MK
    J Mol Cell Cardiol; 2018 Oct; 123():46-57. PubMed ID: 30138626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.
    Liu J; Zhuang T; Pi J; Chen X; Zhang Q; Li Y; Wang H; Shen Y; Tomlinson B; Chan P; Yu Z; Cheng Y; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y
    Circulation; 2019 Aug; 140(8):665-680. PubMed ID: 31177814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting the MAPK pathway improves heart failure with preserved ejection fraction induced by salt-sensitive hypertension.
    Li S; Shi Y; Yuan S; Ruan J; Pan H; Ma M; Huang G; Ji Q; Zhong Y; Jiang T
    Biomed Pharmacother; 2024 Jan; 170():115987. PubMed ID: 38056241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-β1 impairs CFTR-mediated anion secretion across cultured porcine vas deferens epithelial monolayer via the p38 MAPK pathway.
    Yi S; Pierucci-Alves F; Schultz BD
    Am J Physiol Cell Physiol; 2013 Oct; 305(8):C867-76. PubMed ID: 23903699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAX1BP1 downregulation by STAT3 in cardiac fibroblasts contributes to diabetes-induced heart failure with preserved ejection fraction.
    Zuo GF; Wang LG; Huang L; Ren YF; Ge Z; Hu ZY; Zhang JJ; Chen SL
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166979. PubMed ID: 38065272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF-β1/Smad3 signalling pathway.
    Li N; Hang W; Shu H; Zhou N
    J Cell Mol Med; 2022 Aug; 26(16):4548-4555. PubMed ID: 35861038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
    Wu H; Tang LX; Wang XM; Li LP; Chen XK; He YJ; Yang DZ; Shi Y; Shou JL; Zhang ZS; Wang L; Lu BJ; An SM; Zeng CY; Wang WE
    Acta Pharmacol Sin; 2023 Jun; 44(6):1149-1160. PubMed ID: 36473990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tea Polyphenols Regulate Renin-angiotensin-aldosterone System and Transforming Growth Factor-β1/Smads Signaling Pathway in Heart Failure Rats].
    Wan LF; Yuan ZJ; Chen H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):384-391. PubMed ID: 35791933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMM-H007 improves heart function via reducing cardiac fibrosis.
    Ge W; Zhang W; Gao R; Li B; Zhu H; Wang J
    Eur J Pharmacol; 2019 Aug; 857():172442. PubMed ID: 31181209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of BMP-2 antagonizes TGF-β1/ROCK-enhanced cardiac fibrotic signalling through activation of Smurf1/Smad6 complex.
    Wang S; Sun A; Li L; Zhao G; Jia J; Wang K; Ge J; Zou Y
    J Cell Mol Med; 2012 Oct; 16(10):2301-10. PubMed ID: 22283839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of lncR-30245 in Myocardial Infarction-Induced Cardiac Fibrosis Through Peroxisome Proliferator-Activated Receptor-γ-Mediated Connective Tissue Growth Factor Signalling Pathway.
    Zhuang Y; Li T; Zhuang Y; Li Z; Yang W; Huang Q; Li D; Wu H; Zhang G; Yang T; Zhan L; Pan Z; Lu Y
    Can J Cardiol; 2019 Apr; 35(4):480-489. PubMed ID: 30935639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fus knockdown inhibits the profibrogenic effect of cardiac fibroblasts induced by angiotensin II through targeting Pax3 thereby regulating TGF-β1/Smad pathway.
    Wang G; Wu H; Liang P; He X; Liu D
    Bioengineered; 2021 Dec; 12(1):1415-1425. PubMed ID: 33896391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.